Fundraising Fox

Third Rock Ventures2016 Investments

4 investments dated 2016 · listed companies and verified rows first · show all

Fulcrum TherapeuticsNASDAQ: FULCJul 2016SEC filinghigh confidence

BiotechCambridge, US

Robert Gould(Executive Officer, Director)

BoardAlan Ezekowitz(Director)inJames Geraghty(Director)James Collins(Director)

Board seatMark Levin· per SEC Form D · $55M raise · filed Jul 2017

Co-investorsForesite Capital

Element Sciencemyjewel.cominAug 2016

Jewel is a wearable patch cardioverter defibrillator designed to provide continuous protection from sudden cardiac arrest, using machine learning to minimize false alarms while requiring no daily maintenance for up to a week.

AI & Machine LearningHealthtechMedical DevicesSan Francisco, US

Uday N. Kumar(Executive Officer, Director)William Kucheman(Director)

BoardRussell Hirsch(Director)Krishna Yeshwant(Director)inWilliam H. Kucheman(Director)

Board seatNeil Exter· per SEC Form D

Co-investorsDeerfield Management CompanyGV (Google Ventures)

ImaginabMar 2016SEC filingmedium confidence

BiotechInglewood, US

Anna M. Wu(Executive Officer, Director)Jeffrey D. Quan(Executive Officer)Benjamin Chen(Executive Officer)Valerie Calenda(Director)Anna W. Work(Director)Jennifer Keppler(President and Chief Operating Officer)

Board seatAbbie Celniker· per SEC Form D · $9.5M raise · filed Apr 2016

Neon Therapeuticsneontherapeutics.comDec 2016

BiotechCambridge, US

Richard Gaynor, M.D.(Executive Officer)Robert Ang, M.D.(Executive Officer)Yasir Al-Wakeel(Executive Officer)Eric Lander(Director)Hugh Dowd(Executive Officer, Director)

BoardCary Pfeffer, M.D.(Director)

Board seatRobert KamenRobert Tepper· per SEC Form D

Co-investorsNextech InvestSofinnova VenturesClal Biotechnology Industries

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.